Glioblastoma multiforme: Diagnosis, treatment, and invasion
Мультиформная глиобластома: диагностика, лечение и инвазия
2022-10-11
SCID: 54.1/yhjxaew8
Discuss with AI
Brain tumor invasionChemotherapy resistanceGBM treatmentGlioblastoma multiformeTumor recurrence and progression
Figures from the paper
Abstract (AI)
Glioblastoma multiforme (GBM) is an essentially incurable brain tumor, which has been explored for approximately a century. Nowadays, surgical resection, chemotherapy, and radiation therapy are still the standardized therapeutic options. However, due to the intrinsic invasion and metastasis features and the resistance to chemotherapy, the survival rate of glioblastoma patients remains unsatisfactory. To improve the current situation, much more research is needed to provide comprehensive knowledge of GBM. In this review, we summarize the latest updates on GBM treatment and invasion. Firstly, we review the traditional and emerging therapies that have been used for GBM treatment. Given the limited efficiency of these therapies, we further discuss the role of invasion in GBM recurrence and progression, and present current research progress on the mode and mechanisms of GBM invasion.
Key Findings
1
GBM invasion plays a central role in tumor recurrence and progression.
2
Glioblastoma multiforme remains essentially incurable despite approximately a century of research.
3
Intrinsic invasion, metastasis, and chemotherapy resistance contribute substantially to poor patient survival.
4
Surgical resection, chemotherapy, and radiation therapy remain standard GBM treatments, but their effectiveness is limited.
5
The review summarizes traditional and emerging therapies and discusses current research on the modes and mechanisms of GBM invasion.
Research Object
glioblastoma multiforme (GBM)
Research Subject
GBM treatment and invasion, including therapeutic efficacy, recurrence and progression, and the modes and mechanisms of invasion
Publication Details
Publication Date
2022-10-11
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest